The short version of Drug affinity complex fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2025-12-08. Anything still debated is marked as such rather than presented as settled.
CJC-1295 is a synthetic analogue of growth hormone-releasing hormone, built on the 29-amino-acid GHRH(1-29) fragment. Four substitutions distinguish it from the natural sequence: D-alanine at position 2, glutamine at position 8, alanine at position 15, and leucine at position 27. These changes reduce enzymatic cleavage and extend the peptide's persistence in circulation. The compound is discussed in two forms, one carrying a drug affinity complex and one without it.
The drug affinity complex is a maleimidopropionic acid group attached to a lysine side chain. It reacts with the free thiol of cysteine-34 on circulating albumin, forming a covalent bond. This conjugation keeps the peptide in the bloodstream and shields it from rapid renal filtration and proteolysis. Reported circulation half-lives for the albumin-bound form fall in the range of roughly six to nine days in early human studies.
Binding to GHRH receptors on pituitary somatotroph cells triggers cyclic AMP signaling and stimulates growth hormone synthesis and release. Because the peptide acts upstream of the pituitary, effects are mediated through endogenous growth hormone rather than direct receptor activation in peripheral tissues. Increases in insulin-like growth factor 1 are generally described as a downstream consequence. Most published human exposure data come from small early-stage studies, and the clinical significance of the pharmacokinetic profile remains incompletely characterized.
CJC-1295 is a synthetic peptide designed to mimic growth hormone-releasing hormone (GHRH), the endogenous signal that prompts the pituitary gland to release growth hormone. The compound is a modified fragment of the natural hormone, spanning the first twenty-nine amino acids of GHRH with several substitutions that slow enzymatic breakdown. Two variants circulate in research settings: one carrying a drug affinity complex (DAC) and one without it. The DAC-free form is frequently labelled Mod GRF(1-29) in catalogs and discussion forums.
The peptide binds GHRH receptors on somatotroph cells within the anterior pituitary, triggering a signalling cascade that increases growth hormone secretion. Its improved resistance to dipeptidyl peptidase IV degradation distinguishes it from the parent hormone. In the DAC-bearing version, a maleimide group reacts with a cysteine residue on serum albumin, forming a covalent bond that keeps the peptide in circulation far longer. That albumin attachment is the central design feature separating the two research variants.
| Property | Value | Notes |
|---|---|---|
| Physical form | Lyophilized white powder | Supplied as a freeze-dried solid for research use |
| Molecular weight | Approximately 3,647 Da (DAC form) | Lower for the variant lacking the albumin-binding moiety |
| Solubility | Soluble in water and aqueous buffer | Typically dissolved in sterile or bacteriostatic water |
| Typical storage temperature | −20 °C or below | Dry powder, desiccated and protected from light |
| Common analytical method | Reversed-phase HPLC with mass spectrometry | Used for purity estimation and identity confirmation |
The distinguishing feature of the DAC form is a maleimide-containing group that reacts with the free thiol of cysteine-34 on human serum albumin. This reaction forms a covalent bond without enzymatic assistance, and it takes place after the peptide enters the bloodstream. Because albumin is abundant and long-lived, the attached peptide is carried through circulation far longer than an unmodified fragment would survive. The chemistry is a deliberate pharmacokinetic strategy rather than a change to receptor activity.
Enzymatic protection is a separate mechanism from plasma protein binding. The four substitutions in the backbone reduce recognition by dipeptidyl peptidase IV, which normally cleaves the natural hormone within minutes. Without the reactive group, this resistance still yields only a short window of activity, generally reported in the range of tens of minutes. With it, reported half-lives in early human work extended to several days. The size of that gap is the main practical distinction between the two materials.
CJC-1295 is the name used for a synthetic peptide modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. The compound was described by a Canadian drug discovery company in the mid-2000s as a long-acting research tool. Two closely related molecules share the name in practice: one carries a drug affinity complex, or DAC, group, and one does not. The distinction matters because the two behave differently in circulation.
The peptide backbone corresponds to GRF(1-29), the first 29 residues of native growth hormone-releasing hormone, which retains most of the receptor-activating activity of the full-length molecule. Four substitutions distinguish the analog from the natural sequence: D-alanine at position 2, glutamine at position 8, alanine at position 15, and leucine at position 27. These changes slow cleavage by dipeptidyl peptidase IV, the enzyme that degrades native hormone in plasma within minutes. The outcome is improved enzymatic stability combined with a still brief residence time when no additional modification is present.
The albumin-binding version stays in circulation for days, because covalent attachment to serum albumin shields the peptide from rapid filtration and degradation. Reported half-lives for this form fall in the range of several days. The version without the linker is cleared in minutes, with estimates often near thirty minutes in animal work. These figures come from small studies and vary with assay method, species, and route, so they are best read as approximate rather than fixed constants.
Studies in this area generally track growth hormone pulses, insulin-like growth factor 1 concentrations, and occasionally body composition endpoints. Most published human data come from early, small trials, and questions about long-term effects remain open. Whether repeated exposure alters pituitary responsiveness over time is not settled. Analytical work relies on immunoassays for the hormones and on mass spectrometry for the peptide itself, because the two measurements answer different questions.
Studies in bird behaviour include the use of tamed and trained birds in captivity. Studies on bird intelligence and song learning have been largely laboratory-based. Field researchers may make use of a wide range of techniques such as the use of dummy owls to elicit mobbing behaviour, and dummy males or the use of call playback to elicit territorial behaviour and thereby to establish the boundaries of bird territories. Studies of bird migration including aspects of navigation, orientation, and physiology are often studied using captive birds in special cages that record their activities. The Emlen funnel, for instance, makes use of a cage with an inkpad at the centre and a conical floor where the ink marks can be counted to identify the direction in which the bird attempts to fly. The funnel can have a transparent top and visible cues such as the direction of sunlight may be controlled using mirrors or the positions of the stars simulated in a planetarium. The entire genome of the domestic fowl (Gallus gallus) was sequenced in 2004, and was followed in 2008 by the genome of the zebra finch (Taeniopygia guttata). Such whole-genome sequencing projects allow for studies on evolutionary processes involved in speciation. Associations between the expression of genes and behaviour may be studied using candidate genes. Variations in the exploratory behaviour of great tits (Parus major) have been found to be linked with a gene orthologous to the human gene DRD4 (Dopamine receptor D4) which is known to be associated with novelty-seeking behaviour.
{\displaystyle {\begin{array}{lll}M({\ce {H2}})&=2\times 1.00794(7)\times M_{\mathrm {u} }&=2.01588(14){\text{ g/mol}}\\M({\ce {N2}})&=2\times 14.0067(2)\times M_{\mathrm {u} }&=28.0134(4){\text{ g/mol}}\\M({\ce {O2}})&=2\times 15.9994(3)\times M_{\mathrm {u} }&=31.9988(6){\text{ g/mol}}\\M({\ce {S8}})&=8\times 32.065(5)\times M_{\mathrm {u} }&=256.52(4){\text{ g/mol}}\\M({\ce {Cl2}})&=2\times 35.453(2)\times M_{\mathrm {u} }&=70.906(4){\text{ g/mol}}\end{array}}}
If we can't hold ourselves up as an example of how to treat people with dignity and respect, we can't ask that other nations do that to our soldiers." On May 1, 2004, photos of prisoners at Abu Ghraib prison in Iraq being abused and humiliated by United States soldiers provoke an international outrage. Furthering the charges, excerpts from the Abu Ghraib Taguba report were published on May 3, 2004. The report documented: the sodomizing of a prisoner with a chemical light, pouring phosphoric liquid on detainees, rape of a female prisoner, forced masturbation, "ghost detainees" moved around to avoid the Red Cross, and many other abuses. The release of the photographs and reports had led to renewed calls for investigations into the abuses reported in other US military prisons, such as Camp X-Ray and Camp Delta. On May 14, 2004, reporters for the Guardian documented a coercive technique which soldiers called "bitch in a box". The prisoner was shoved into the trunk of a car on a hot day, and driven around until the prisoner was near ready to pass out. Another technique documented was "waterboarding", which involves water being poured over a cloth covering the face and breathing passages of an immobilized captive, causing the individual to experience the sensation of drowning. They also interviewed many soldiers not involved in the current scandal, who claimed that they were taught to use sleep deprivation, to stage mock executions, and to use other procedures. One platoon leader who objected to these practices was reportedly told that his stand could end his military career.
Sources: en.wikipedia.org
Tea was consumed as a recreational and social beverage during the Tang dynasty, and Chinese tea culture-inspired ceremonial drinking spread to other Sinospheric countries such as Japan (where it is known as chado), Korea (known as darye) and Vietnam (typically as part of a wedding ritual). Tea drinking also spread into Inner Asia and South Asia via the Silk Road and the Tea Horse Road, particularly during the expansion of the Mongols, for whom the salted milk tea (süütei tsai) has remained part of the staple diet. Outside of the Far East, Portuguese priests and merchants introduced tea drinking to Europe during the 16th century. During the 17th century, drinking tea became fashionable in Western Europe as part of the rise of Chinoiserie influence, especially among the British, who had such a high import demand of tea that they later started to cultivate tea on a large scale in colonial India and Ceylon, where tea had previously been used only as a herbal medicine.
Because of this, despite Hua Tuo's reported success with general anesthesia, the practice of surgery in ancient China ended with his death. The name mafeisan combines ma (麻, meaning "cannabis, hemp, numbed or tingling"), fei (沸, meaning "boiling or bubbling"), and san (散, meaning "to break up or scatter", or "medicine in powder form"). Therefore, the word mafeisan probably means something like "cannabis boil powder". Many sinologists and scholars of traditional Chinese medicine have guessed at the composition of Hua Tuo's mafeisan powder, but the exact components still remain unclear. His formula is believed to have contained some combination of:
==== Return to Frankfurt University ==== Upon his return, Adorno helped shape the political culture of West Germany. Until his death in 1969, twenty years after his return, Adorno contributed to the intellectual foundations of the Federal Republic as a professor at the University of Frankfurt am Main, critic of the vogue enjoyed by Heideggerian philosophy, partisan of critical sociology, and teacher of music at the Darmstadt International Summer Courses for New Music. Adorno resumed his teaching duties at the university soon after his arrival, with seminars on "Kant's Transcendental Dialectic," aesthetics, Hegel, "Contemporary Problems in the Theory of Knowledge," and "The Concept of Knowledge." Adorno's surprise at his students' passionate interest in intellectual matters did not, however, blind him to continuing problems within Germany: The literary climate was dominated by writers who had remained in Germany during Hitler's rule, the government re-employed people who had been active in the Nazi apparatus, and people were generally loath to own up to their own collaboration or the guilt they thus incurred. Instead, the ruined city of Frankfurt continued as if nothing had happened, holding on to ideas of the true, the beautiful, and the good despite the atrocities, hanging on to a culture that had itself been lost in rubble or killed off in the concentration camps. All the enthusiasm Adorno's students showed for intellectual matters could not erase the suspicion that, in the words of Max Frisch, culture had become an "alibi" for the absence of political consciousness.
Sources: en.wikipedia.org
The two share the same 29-amino-acid backbone. CJC-1295 carries an additional albumin-binding moiety that markedly extends its residence time in circulation, while the form without that moiety clears faster. Literature sometimes applies the name loosely to either variant.
It has not been approved by major regulatory agencies for any therapeutic indication. Material sold under this name is typically distributed for laboratory research only. Clinical use is not supported by large controlled trials.
Early human studies of the albumin-binding form reported circulation half-lives on the order of several days. The value depends on assay method and study design. Estimates for the form without the binding moiety are considerably shorter.
The synthetic peptide keeps the receptor-binding region of GHRH but carries substitutions that resist enzymatic cleavage. In the DAC version, an added group also anchors the molecule to albumin, extending its presence in the bloodstream.